Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Jesse was two years old when he was diagnosed with B-cell acute lymphoblastic leukaemia, a type of blood and bone marrow ...

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 potential cancer-driving genes, 74 of which are newly associated with ...

Members of The Institute of Cancer Research, London’s Discovery Club, our high-level giving club of visionary supporters, learned about the difference that philanthropy is making to people with cancer ...

We will deliver benefits for cancer patients by developing smarter, kinder treatments through innovative clinical trials and taking advances into NHS care. The ICR and The Royal Marsden bring together ...

Image: Blood samples in tubes. Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best targeted treatment quickly before it spreads – ...

This Christmas, give the gift of research to help someone's mum, sister, nan, or friend survive cancer and look forward to spending more precious time with their loved ones. "I’m here to tell my story ...

Image: The Man Van. Credit: The Man Van and The Royal Marsden NHS Foundation Trust. Mobile testing ‘Man Van’ can diagnose ...

Our work towards becoming more sustainable starts with our buildings, estates and facilities. Every day our facilities rely on resources such as energy and water to carry out our research and we also ...

Every year for International Day of Women and Girls in Science, and International Women's Day, we shine a spotlight on some of the many fantastic women leading the way at the ICR. Through different ...